Suppr超能文献

他汀不耐受——定义问题。

Statin intolerance - a question of definition.

作者信息

Algharably Engi Abdel-Hady, Filler Iris, Rosenfeld Stephanie, Grabowski Katja, Kreutz Reinhold

机构信息

a Institut für Klinische Pharmakologie und Toxikologie , Charité - Universitätsmedizin Berlin , Berlin , Germany.

b Department of Clinical Pharmacy, Faculty of Pharmacy , Ain Shams University , Cairo , Egypt.

出版信息

Expert Opin Drug Saf. 2017 Jan;16(1):55-63. doi: 10.1080/14740338.2017.1238898. Epub 2016 Sep 27.

Abstract

Statin therapy is the backbone of pharmacologic therapy for low-density lipoproteins cholesterol lowering and plays a pivotal role in cardiovascular disease prevention. Statin intolerance is understood as the inability to continue using a statin to reduce individual cardiovascular risk sufficiently, due to the development of symptoms or laboratory abnormalities attributable to the initiation or dose escalation of a statin. Muscle symptoms are the most common side effects observed. Areas covered: The main aim of this article is to present a review on published definitions of statin intolerance. In addition, a brief review on clinical aspects and risk factors of statin intolerance is provided and features for a common definition for statin intolerance are suggested. Expert opinion: A definition of statin intolerance by major drug regulatory agencies is not available. In clinical studies, different definitions are chosen and results are not comparable; different medical associations do not agree on one common definition. There is an unmet need to establish a common definition of statin intolerance to ensure an appropriate clinical use of this important drug class. Further work is required to develop a consensus definition on statin intolerance that could have significant positive impact on both research and clinical management.

摘要

他汀类药物治疗是降低低密度脂蛋白胆固醇的药物治疗的基础,在心血管疾病预防中起着关键作用。他汀类药物不耐受被理解为由于开始使用他汀类药物或增加剂量后出现症状或实验室异常,而无法继续使用他汀类药物充分降低个体心血管风险。肌肉症状是观察到的最常见副作用。涵盖领域:本文的主要目的是对已发表的他汀类药物不耐受定义进行综述。此外,还简要综述了他汀类药物不耐受的临床方面和危险因素,并提出了他汀类药物不耐受通用定义的特征。专家意见:主要药物监管机构尚未给出他汀类药物不耐受的定义。在临床研究中,选择了不同的定义,结果不可比;不同的医学协会对一个通用定义也未达成一致。迫切需要建立他汀类药物不耐受的通用定义,以确保这类重要药物的合理临床应用。需要进一步开展工作,以制定关于他汀类药物不耐受的共识定义,这可能对研究和临床管理产生重大积极影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验